Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >50 highly experienced drug discovery and industry professionals and built and operated multiple new successful companies; these companies have raised significant funds through Series B, IPO and an exit through a trade sale.
Ridgeline is expanding its capabilities in Basel to support the creation of a new company focused on cardiovascular and metabolic diseases. To this purpose, we are seeking a
Project Manager with proven expertise in coordinating
small molecule discovery activities ideally in the field of
cardiovascular and metabolic preclinical research.